Insys Therapeutics beats by $0.23, beats on revenues

|About: Insys Therapeutics, Inc. (INSY)|By:, SA News Editor

Insys Therapeutics (INSY): Q2 EPS of $0.35 beats by $0.23.

Revenue of $18.8M beats by $3.73M. (PR)